Summary In the present study the putative chemopreventive effect of dietary fish oil (MaxEPA) on azaserineinduced pancreatic carcinogenesis in rats was investigated. Groups of rats were maintained on a semipurified low-fat (LF; 5 wt%) diet or on semipurified high-fat (HF; 25 wt%) diets containing 5 wt% linoleic acid (LA) and including 0.0, 1.2, 2.4, 4.7, 7.1 or 9.4 wt% MaxEPA. Animals fed a HF diet developed significantly higher mean numbers of atypical acinar cell nodules (AACNs), adenomas and carcinomas than animals fed a LF diet. Dietary MaxEPA caused a significant (P<0.01) dose-related increase in mean number of AACNs (0.5 <0 < 3.0 mm). The mean number of adenomas and carcinomas remained similar among the groups. Cell proliferation was significantly lower in AACNs from animals fed HF containing 9.4% MaxEPA in comparison with HF without MaxEPA and with LF. LA levels had increased and arachidonic acid (AA) levels had decreased in blood plasma and pancreas with increasing dietary MaxEPA. Feeding MaxEPA resulted in significant decreases in 6-keto-prostaglandin (PG) Fl,, (P < 0.05) and PGF2, (P < 0.01) in non-tumorous pancreas, whereas PGE2, PGF2,, and thromboxane B2 (TXB2) levels were significantly (P<0.001) higher in pancreatic tumour tissue than in non-tumorous pancreatic tissue. It is concluded that (i) dietary MaxEPA enhances dose-relatedly growth of putative preneoplastic AACNs in the pancreas of azaserine-treated rats; (ii) dietary MaxEPA inhibits the conversion of LA to AA, as well as the conversion of AA to TXB2 or PGF2,, in non-tumorous pancreatic tissue; (iii) the high levels of PGE2, PGF2,, and TXB2 in pancreatic adenocarcinomas indicate a possible role for these eicosanoids in modulation of tumour growth.
Polyunsaturated fatty acids (PUFAs) from the w-3 family (abundant in fish oil) have been shown to inhibit tumour development in animal models for mammary (Jurkowski and Cave, 1985) , colon (Reddy and Sugie, 1988) and pancreatic carcinogenesis. Information on effects of fish oil on pancreatic carcinogenesis is scarce and comes mainly from the studies of O'Connor et al. (1985) , who observed that in azaserine-treated rats maintained on a 20% menhaden oil (MO) diet for 4 months, the number and size of pancreatic preneoplastic atypical acinar cell nodules (AACNs) were significantly reduced as compared with rats fed a 20% corn oil (CO) diet. In a subsequent 4 month study they found a decrease in the number of AACNs with increasing levels of MO in a 20% fat diet (O'Connor et al., 1989) . However, using the same model, we did not find any difference in AACN yield in rats fed 25% fat diets with a constant 5% linoleic acid (LA) level, either or not containing 9.4% fish oil (MaxEPA), for 6 months . Because of the latter unexpected and contrasting result and the lack of data on effects of fish oil on development of pancreatic tumours, we performed a 12 month study to investigate the effects of increasing levels of MaxEPA in a 25% fat/5% LA diet on pancreatic tumour development in azaserine-treated rats. Furthermore, the effects of dietary MaxEPA on cell proliferation in AACNs and normal acinar pancreatic tissue, as well as fatty acid profiles and prostaglandin levels in pancreatic tissue were examined.
with wire-mesh floors and fronts and were fed a standard laboratory chow. Two weeks (± 1 day) after arrival the rats gave birth to a mean of eight pups. After 4 days the pups were sexed. All females, the surplus of male pups and the surplus of mothers were killed and a total of 210 male pups were divided among the remaining 26 mothers. One hundred and seventy-five pups were given an i.p. injection of 30 mg azaserine (Calbiochem-Behring, La Jolla, CA, USA) per kg body wt, which was dissolved freshly in 0.9% sodium chloride solution, at 14 and 21 days of age. Thirty-five control pups received injections with sodium chloride solution alone. Directly after the second injection the animals were weaned and randomly allocated to seven groups of 30 animals each (five control animals and 25 azaserine-treated animals). The animals were kept in stainless steel cages, with wire-mesh floors and fronts, five animals per cage and under standard laboratory conditions. One week after carcinogen treatment the rats were fed an AIN76-based purified diet containing either 5 or 25 wt% fat. The control group received a S wt% lard (Best Food, The Netherlands; LF) diet, containing a marginal (0.61 wt%) but sufficient level of linoleic acid (LA; National Research Council Subcommittee, 1978) . The experimental groups received a high-fat (25 wt%; HF) diet containing 5 wt% LA and including 0.0, 1.2, 2.4, 4.7, 7.1 or 9.4 wt% (0, 2.5, 5, 10, 15 and 20 en%) MaxEPA. The experimental design is summarised in Table I 
Results
Food consumption and body and organ weights Mean food consumption of rats maintained on an LF diet was significantly (P<0.001) higher than that in rats main- (Table IV) . Mean body weight gain over the study showed no significant differences among the groups (Figure 2 ). Mean terminal body weights of animals fed a HF diet were significantly higher relative to animals fed a LF diet (P<0.05; Table V) . Azaserine treatment caused a consistent, significant increase in both absolute and relative pancreas weights in all groups (P<0.001) in comparison with salinetreated controls. Both absolute and relative liver weights were significantly higher in animals kept on a HF diet than in LF controls (P<0.01 and P<0.05 respectively).
Microscopy
Feeding a HF diet significantly enhanced tumour growth in comparison with the LF control diet, as reflected by a significantly higher number of tumour-bearing animals (P<0.001), number of AACNs (P<0.01) and total number of carcinomas (P<0.05). Including MaxEPA in the HF diet resulted in a significant dose-related linear increase in number of AACNs with both a diameter of 0.5 -1.0 mm as well as a diameter of 1.0-3.0 mm (P<0.01). A similar effect was seen on the volume of pancreas occupied by AACNs (P<0.01). No such effect was seen on the number of adenomas and carcinomas or on the number of tumour-bearing animals (Table VI and : 2), arachidonic acid (AA; C20:4), eicosapentaenoic acid (EPA; C20:5) and docosahexaenoic acid (DHA; C22:6).
In blood plasma the levels of AA (C20:4) and DHA (C22:6) were significantly higher in saline-treated vs azaserine-treated rats (P<0.001). In pancreatic microsomes the level of OA (C18:1) was significantly higher (P<0.05) and the levels of AA (C20:4), EPA (C20:5) and DHA (C22 :6) were significantly lower (P <0.001, P <0.05 and P<0.001 respectively) in saline-treated rats in comparison with azaserine-treated rats.
In blood plasma and pancreas the levels of OA (C18:1) decreased and the levels of EPA (C20:5) and DHA (C22:6) increased, parallel to the dietary supply of these fatty acids. Levels of LA (C18:2) increased and AA (C20:4) decreased in both blood plasma and pancreas of saline-and azaserinetreated rats. Significant linear increases were observed in levels of LA (C18:2; P<0.001), EPA (C20:5; P<0.001) and DHA (C22:6;P <0.001) and significant linear decreases were observed in levels of OA (C18:1; P<0.01) and AA (C20:4; P<0.001; except for C20:4 in pancreas of saline-treated rats: P =0.926).
LA (C 18:2) levels in microsomes from tumours were significantly lower in all diet groups measured (P <0.05, at least), whereas AA (C20:4) levels were significantly elevated in tumours from animals fed 2.4% and 4.7% MaxEPA in comparison with non-tumorous pancreas from azaserinetreated rats (P <0.01). No differences were found in EPA and DHA profiles, except for the DHA level in tumours from the group fed 2.4% MaxEPA, which was significantly higher in comparison with non-tumorous tissues (P<0.001). The profiles of LA (C1 8:2), AA (C20:4), EPA (C20:5) and DHA (C22:6) in pancreatic tumours are depicted in Figure 5 .
Prostglandins
Pancreatic 6-keto-PGF1,-and PGF2, levels were significantly lower in saline-treated rats maintained on the HF diet containing 4.7% and 9.4% MaxEPA, in comparison with salinetreated rats maintained on the HF diet without MaxEPA (P < 0.05 and P < 0.01, for the respective prostaglandins). In azaserine-treated rats PGF20 levels were significantly lower (P <0.05) in pancreata from animals fed 9.4% MaxEPA in comparison with those from animals fed the HF diet without MaxEPA. Pancreatic PGF20 and TXB2 levels were inversely related to the percentage of dietary MaxEPA in both salineand azaserine-treated rats. Parts of all grossly visible pancreatic rat tumours were analysed for prostaglandins. Microscopic examination of the grossly visible pancreatic lesions indicated that the number of adenocarcinomas in the group given high fat without MaxEPA was high enough (n = 3) to justify statistical analysis. PGE2, TXB2, PGF2O, but not 6-keto-PGF1, levels in pancreatic adenocarcinomas were significantly elevated (P <0.001) in comparison with nontumorous pancreas from azaserine-treated rats (Figure 6 ). The results of the present study demonstrated a strong enhancing effect of HF (25 wt%) diet including 5 wt% LA on pancreatic carcinogenesis in azaserine-treated rats. Moreover, including various amounts of fish oil (MaxEPA) in the HF diet resulted in a significant dose-related linear increase in the number of putative preneoplastic AACNs with a diameter between 0.5 and 3.0 mm. It appeared that long-chain PUFAs of the w-3 series from fish oil in the diet are readily taken up by the rat, resulting in increased concentrations in both plasma and pancreas, concomitant with increasing concentrations in the feed. The presence of MaxEPA in the diet significantly decreased cell proliferation in AACNs and influenced the metabolism of linoleic acid, arachidonic acid and and hence prostaglandin synthesis substantially.
In a number of studies the chemopreventive effect of dietary fish oil has been reported in experimental mammary gland carcinogenesis (Jurkowski and Cave, 1985; Braden and Carroll, 1986; Ip et al., 1986; Abou-El-Ela et al., 1989) , colon carcinogenesis (Minoura et al., 1988; Reddy and Maruyama, 1986; Reddy and Sugie, 1988) and pancreatic carcinogenesis (O'Connor et al., 1985; . To investigate the effects of fish oil (containing high concentrations of w-3 fatty acids), most investigators used mixtures of corn oil and fish oil or fish oil as such. Most of the studies that had the intention of varying o-3 fatty acids in the diet, had an experimental design also resulting in a variation in dietary w-6 fatty acid levels. Moreover, in those studies where fish oil was used as sole lipid source, the level of w-6 fatty acid frequently was a deficient one. O'Connor et al. (1985) reported that 20% MO caused a significant inhibition of the growth of azaserine-induced AACNs in rat pancreas as compared with a 20% CO diet. In a subsequent study (O'Connor et al., 1989) , they varied the w-3/w-6 ratio from 0.01 up to 7.0 by mixing CO with MO and observed a significant decrease in development of AACN with increasing ratio of w-3/w-6. They acknowledged that their dietary regimen also implied a variation of dietary LA from 0.6% up to 12.0%, which is within the range in which growth of AACN is significantly increased (4.4-8.5%; Roebuck et al., 1985) . In a previous study , we varied the dietary LA levels from 2.0% to 15.0%, without influencing the chain length of the fatty acids, and observed an inverse rather than a positive dose-response relationship between LA and AACN development. In order to minimise the number of variables and their possible confounding effects, it seems of paramount importance to keep LA in the diet at a constant level when investigating the effects of other variables such as dietary fish oil. In the present study an increase of MaxEPA paralleled a decrease of oleic acid (OA). OA has been reported to enhance the growth of pancreatic AACNs (Khoo et al., 1991) . However, in this study pancreatic AACNs were absent in the group treated with azaserine alone and in the other groups the yield Figure 4 Labelling index of normal and preneoplastic pancreatic tissue (AACN) in rats maintained on a 5 wt% fat AIN76-based diet, a 25 wt% fat AIN76-based diet or a 25% fat AIN76-based diet containing 9.4 wt% MaxEPA for 12 months. Statistics: analysis of variance followed by Student's t-tests. *P<0.05. *, Normal tissue; _, AACN. of AACNs was unusually low for the experimental protocol used (30 mg of azaserine per kg body wt at 14, 21 and 28 days of age, followed by a 6 month feeding period). In our studies dietary OA either correlated negatively (present results) or positively with the development of AACNs. Apart from the isolated study by Khoo et al., OA has not been implicated as a promoter in carcinogenesis. Moreover, since OA cannot be metabolised to LA or other long-chain PUFAs and prostaglandins, the findings of Khoo et al. (1989) are hard to explain mechanistically. In our view, the influence of OA on pancreatic carcinogenesis seems to be of minor importance.
Apart from the importance of an adequate study design, the present results also emphasise that an enhancing effect on growth of early stages in pancreatic carcinogenesis (AACNs), does not necessarily lead to more carcinomas. Consequently, a long-term (12-15 months) study is needed to establish the modulating effects of dietary or other factors on the development of the ultimate pancreatic tumours. The observation that after 12 but not after 6 months an enhancing effect of fish oil on the growth of AACNs is seen, suggests that fish oil modulated pancreatic carcinogenesis in azaserine-treated rats only after a rather long period of feeding. Moreover, it cannot be excluded that prolonged feeding of diets high in MaxEPA for over 12 months will also finally modulate development of pancreatic carcinomas. The significantly higher LI of the acidophilic AACNs vs normal acinar tissue, as observed in the present study, is in agreement with the previously observed high growth potential of these putative preneoplastic lesions (Rao et al., 1982) . Although MaxEPA caused a dose-related increase in number of AACNs, the LI of AACNs in the pancreas of animals maintained on the HF diet including 9.4% MaxEPA was significantly lower than the LI of AACNs present in the pancreas of rats fed the HF diet without MaxEPA. This seemingly contradictory observation may be due to MaxEPA-induced differences in cell turnover, possibly caused by decreased apoptotic cell death. The relation between cell proliferation and programmed cell death is currently under investigation at our Institute.
The main compositional changes in fatty acids in blood plasma and pancreas as a result of increasing MaxEPA in the diet were a decrease in OA (C18: 1) and increases in EPA (C20:5) and DHA (C22:6). An increasing level of dietary MaxEPA caused a shift in the ratio of EPA/DHA from equal or higher than 1 towards an EPA/DHA ratio of equal or less than 1, both in plasma and pancreas. An explanation for this interesting observation may be formation of DHA from EPA. This newly formed DHA accompanied by DHA from the diet accumulates, resulting in higher DHA levels than EPA levels in plasma and tissue (Mathias and Dupont, 1989) . Furthermore, the presently observed fatty acid profiles 6K-PGFia TXB2
PGF2a
Figure 6 Prostaglandin levels in pancreas of (a) saline-treated rats and (b) azaserine-treated rats. Statistics: analysis of variance followed by Student's t-test. *P<0.05, **P<0.01, ***P<0.001.
NS, not significant.
show that feeding MaxEPA causes a decrease of AA (C20:4) levels in both blood plasma (saline-and azaserine-treated rats) and pancreatic tissue (azaserine-treated rats), which can be ascribed to either replacement of AA by EPA (Mathias and Dupont, 1989) 
